The <i>MOK</i> gene was identified as a potential biomarker of the C2<sup>LN</sup> MPM subgroup and PF-04691502 sensitivity.<b>Conclusions:</b> We identified a new MPM molecular subgroup that shares common genetic and transcriptomic characteristics.
OPN expression was investigated immunohistochemically in 104 adenocarcinomas and 38 MM and correlated with histological features, including tumour type, grade and proliferation and with expression of activated intermediary EGFR signalling pathway molecules p65, p-AKT, p-ERK, p-STAT-3, and of metalloproteinase (MMP)-1, MMP-2 and MMP-9.